DE3132916A1
(de)
*
|
1981-08-20 |
1983-03-03 |
Kali-Chemie Pharma Gmbh, 3000 Hannover |
1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
US5264576A
(en)
*
|
1992-10-22 |
1993-11-23 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Pyrazolo[4,3-c]pyridines which are intermediates
|
AP1147A
(en)
*
|
1996-05-03 |
2003-02-25 |
Pfizer |
Substituted indazole derivatives and related compounds.
|
EE9900151A
(et)
|
1996-10-14 |
1999-12-15 |
Bayer Aktiengesellschaft |
Heterotsüklüülmetüül-asendatud pürasooliderivaadid
|
WO1999064425A1
(fr)
*
|
1998-06-09 |
1999-12-16 |
Neurogen Corporation |
Thienocycloalkylpyrazoles substitues : ligands specifiques aux sous-type du recepteur de la dopamine
|
IL146465A0
(en)
|
1999-05-14 |
2002-07-25 |
Ortho Mcneil Pharm Inc |
Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
US6927233B1
(en)
*
|
2000-03-17 |
2005-08-09 |
Alcon, Inc. |
5ht2 agonists for controlling IOP and treating glaucoma
|
US6956036B1
(en)
*
|
2000-03-17 |
2005-10-18 |
Alcon, Inc. |
6-hydroxy-indazole derivatives for treating glaucoma
|
US6897231B2
(en)
*
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US7211594B2
(en)
|
2000-07-31 |
2007-05-01 |
Signal Pharmaceuticals, Llc |
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
US20070105841A1
(en)
*
|
2000-08-14 |
2007-05-10 |
Breitenbucher J G |
Method for treating allergies using substituted pyrazoles
|
MXPA03001422A
(es)
|
2000-08-14 |
2004-01-26 |
Johnson & Johnson |
Pirazoles substituidos.
|
MXPA03001421A
(es)
*
|
2000-08-14 |
2004-01-26 |
Johnson & Johnson |
Pirazoles sustituidos.
|
US7332494B2
(en)
*
|
2000-08-14 |
2008-02-19 |
Janssen Pharmaceutica, N.V. |
Method for treating allergies using substituted pyrazoles
|
MXPA03001420A
(es)
|
2000-08-14 |
2004-01-26 |
Johnson & Johnson |
Pirazoles sustituidos.
|
EP1315741A2
(fr)
|
2000-09-06 |
2003-06-04 |
Ortho-McNeil Pharmaceutical, Inc. |
Methode de traitement des allergies
|
US7429599B2
(en)
*
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
US20030073672A1
(en)
*
|
2001-09-05 |
2003-04-17 |
Breitenbucher J. Guy |
Method for treating allergies using substituted pyrazoles
|
BR0212613A
(pt)
*
|
2001-09-19 |
2004-08-31 |
Pharmacia Corp |
Compostos de indazol substituìdos para o tratamento de inflamação
|
CA2478338A1
(fr)
*
|
2002-03-08 |
2003-09-18 |
Signal Pharmaceuticals, Inc. |
Polytherapie destinee a traiter, prevenir ou gerer des troubles proliferatifs et des cancers
|
US20040034084A1
(en)
*
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
DE60328690D1
(de)
*
|
2002-06-12 |
2009-09-17 |
Chemocentryx Inc |
1-aryl-4-substituierte piperazin-derivate zur verwendung als ccr1-antagonisten zur behandlung von entzündungen und immunerkrankungen
|
US7589199B2
(en)
|
2002-06-12 |
2009-09-15 |
Chemocentryx, Inc. |
Substituted piperazines
|
US20050256130A1
(en)
*
|
2002-06-12 |
2005-11-17 |
Chemocentryx, Inc. |
Substituted piperazines
|
US7842693B2
(en)
*
|
2002-06-12 |
2010-11-30 |
Chemocentryx, Inc. |
Substituted piperazines
|
EP2065383A1
(fr)
|
2003-11-19 |
2009-06-03 |
Signal Pharmaceuticals, Inc. |
Composés d'indazoles et procédés d'utilisation associés en tant qu'inhibiteurs de kinase de protéine
|
CN100542534C
(zh)
*
|
2003-12-09 |
2009-09-23 |
凯莫森特里克斯股份有限公司 |
取代的哌嗪
|
US7435831B2
(en)
*
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
CA2558211C
(fr)
*
|
2004-03-03 |
2013-09-03 |
Chemocentryx, Inc. |
Heterocycles d'azote bicycliques et pontes
|
US20070004777A1
(en)
*
|
2005-03-23 |
2007-01-04 |
Bhagwat Shripad S |
Methods for treating or preventing acute myelogenous leukemia
|